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Abstract
Background Preoperative implant planning for breast recon-
struction is often at risk of being changed perioperatively. This
study examined which factors are associated with a change of
implant selection.
Methods Women who had unilateral two-stage breast recon-
struction between 2002 and 2007 were studied. Inclusion
criteria were photographic evidence of preoperative skin
markings indicating breast dimensions and a selected implant
model. Multivariable logistic regression was used to identify
variables associated with a changed selection.
Results Among the 496 women studied, 308 preoperative im-
plant choices (62.1%) were changed during surgery. A change
in plan was significantly associated with symmetrization sur-
gery involving contralateral reduction mammaplasty
(OR = 1.92; 95% CI, 1.12 to 3.29) and contralateral
mastopexy (OR = 2.26; 95% CI, 1.29 to 3.96), but not with
BMI. The required implant width changed more than 0.5 cm
in 70 cases (14.1%) while height changed more than 0.5 cm in
215 cases (43.2%). The likelihood of a change was high for
large preoperative widths (OR = 9.66 for 15.5 cm) and small
preoperative heights (OR = 2.97 for 10.5 cm). At a mean
follow-up of 16.6 months, patient satisfaction was good or
average in 92.1% of cases and 5.9% of implants had been
replaced with another model, indicating that the perioperative
implant selection was usually appropriate.
Conclusions This study documents the frequency with which
implant choices, despite accurate preoperative planning, are
changed perioperatively as a result of relatively small differ-
ences in anthropomorphic measurements. Perioperative recal-
culation of breast dimensions may have an advantage in terms
of patient reoperation rates. Changes in width were less fre-
quent than changes in height and projection. Contralateral
surgery, large width, and small height were the most influen-
tial factors.
Level of Evidence: Level IV, risk / prognostic study.
Keywords Breast reconstruction . Anatomical implant .
Mastectomy . Preoperative planning . Logistic regression .
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Introduction
Before plastic surgery of the breast, the most accurate method
to determine breast volume has long been direct volume and
anthropomorphic measurement [1]. Three-dimensional body
surface imaging by a 3D laser scanner is a new but expensive
alternative to the classical methods of breast volume calcula-
tion such as anthropomorphic measurements, water displace-
ment, thermoplastic castings, and nuclear magnetic resonance
imaging [2–6]. Many studies continue to focus on volume
assessment, but this is a poor method for implant selection
now that anatomical expandable and silicone implants are
available [7, 8].
Preoperative selection of breast implants on the basis of
anthropometric measurements, in particular linear parameters
(width, height, and projection), has been discussed in papers
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describing breast augmentation with the ultimate goal of
achieving symmetry of shape and volume [9–12]. Implants
for breast reconstruction are selected with the same approach
[9–12], but in reconstructive surgery, it is difficult to avoid a
certain degree of breast asymmetry. Preoperative planning for
two-stage (expander and implant) reconstruction usually re-
quires the selection of an anatomical device that matches the
shape and size of the contralateral breast. Contralateral
mammoplasty is considered when asymmetry of shape or size
will potentially be excessive in the minds of the surgeon and
patient. However, preoperative planning, even when accurate,
cannot prevent errors in width, height, and projection mea-
surements as it largely relies on the plastic surgeon’s experi-
ence and predictive capabilities. Moreover, preoperative mea-
surements may not be sufficient for choosing the appropriate
implant because in the perioperative phase, after removal of
the expander, both the reobservation of anatomical features
and the application of surgical refinements at the mastectomy
site may require reevaluation of the anthropometric measure-
ments for the optimal choice of implant. The aim of this ret-
rospective study was to evaluate the relationship between the
preoperative selection and actual choice of the implant in the
perioperative setting in order to determine if there are predict-
able factors that could help standardize implant selection.
Patients and methods
Patients and data collection
We identified women who had undergone mastectomy and
two-stage reconstruction surgery, with placement of a tempo-
rary expander before the final implant, at the Fondazione
IRCCS–Istituto Nazionale dei Tumori, a national comprehen-
sive cancer center, in the six-year period between 2002 and
2007. Patients were included if chest photographs with pre-
operative skin markings indicating the choice of implant were
available. Patients who had undergone bilateral mastectomy
were excluded.
From the clinical records, we collected data on each
patient’s body mass index (BMI), model of implant used
after expander removal, and contralateral breast-matching
procedure (mastopexy, augmentation, reduction mam-
moplasty, or none). We retraced the preoperative plan from
photographs (Fig. 1). In particular, we identified the im-
plant that had been selected during the planning stage. We
also recorded the measurements of breast implant width,
height, and projection (all in centimeters, taken routinely
with the patient standing) and noted if the sternal midline
and inframammary fold (IMF) level had been marked.
When all five of these markings were present and clearly
visible, we considered the preoperative plan complete; if
one or more markings were missing, we considered the
preoperative plan partial. The measurements of breast di-
mensions taken from the photographs were verified against
catalog values; for those cases in which these data were not
retrievable from the photographs, we obtained missing in-
formation from the dimensions of the selected implant.
Data for the weight (g) of each implant were obtained from
the manufacturer’s catalog.
Implant choice
In our unit, breast implants are chosen preoperatively by the
lead surgeon, taking into consideration the following an-
thropomorphic variables: (a) breast width, height, and pro-
jection; (b) soft tissue thickness at the parasternal, upper,
and lateral boundaries of the breast pocket; (c) asymmetry
of the chest wall; (d) discrepancy between the predicted
midpoint of the reconstructed breast and the contralateral
nipple position; (e) IMF contour and level; (f) ptosis; and
(g) possible planned contralateral surgery. Breast size and
shape are subjectively assessed in relation to the expander
volume, the indication for contralateral mammaplasty, and
the patient’s expectations.
During the study period, the implant was initially chosen
from the line of Allergan Inc. (Irvine, US) anatomical implants
(Natrelle styles 410 and 510), which were fully stocked and
readily available within the operating department complex
(the 510 series has been available to us since 2003). The de-
partment also stocked the round implant styles 110 (moderate
profile) and 120 (high profile), which the surgeon could opt
for during the procedure.
Implant preselection
The following anatomical landmarks are essential for the mea-
surements: the midsternal line, suprasternal notch, nipple po-
sition, suprasternal nipple lines, midbreast longitudinal lines,
inframammary transverse line, lateral boundaries, and
inframammary contour of the non-affected breast.
A preliminary step in defining implant dimensions is ob-
servation of the footprint of the contralateral healthy breast.
The contralateral IMF represents the fixed foundation for re-
construction of the missing breast. A flexible ruler is used to
calculate the measurements for width and height, and a caliper
calculates the measurements for projection and soft tissue
thickness as obtained by the pinch test. All measurements
are marked with the patient in the upright position.
The expected width of the reconstructed breast is derived
from the definition of the contralateral breast’s horizontal
boundaries. This width corresponds to the sum of the implant
width and the thickness of the soft tissue overlying the ex-
pander both medially and laterally. The medial limit of the
implant width should not be less than 1 cm from the
midsternal line.
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Correct height does not depend solely on the chest somato-
type or the upper pole desired by the patient. Implant height is
derived from the height of the contralateral breast, but wemust
also take into account possible post-mastectomy soft tissue
loss exceeding the upper boundaries of the breast parenchyma.
Other factors such as rebalancing the nipple-areola complex
after a nipple-sparing mastectomy can modify the expected
height of the reconstructed breast, especially when associated
with augmentation of the contralateral breast.
The projection of the reconstructed breast is derived from
the definition of the contralateral breast projection, which is
calculated by pushing the central part downward and measur-
ing the perpendicular projection of the areola from the chest
wall. This projection corresponds to the addition of the im-
plant projection to the thickness of the soft tissues overlying
the central part of the expander.
Surgical method
For the second stage of breast reconstruction, the preoperative
planning and actual operation were performed by one of six
consultant surgeons having good skill of breast surgery tech-
niques (from 3 to 17 years of specific institutional practice)
and following a standard approach for inscribing the preoper-
ative marks. The practice in our unit is to perform contralateral
surgery for symmetrization, if indicated, during this second
stage, when the expander is replaced with the final implant.
Preoperative planning did not include lipofilling. All opera-
tions were performed under general anesthesia with the patient
positioned supine on the operating table, with the arms
adducted and the elbows in moderate flexion. The position
on the table was secured to allow movement through 90° into
an upright sitting position; this crucial maneuver was always
performed before making the final decision about which im-
plant to use. The mastectomy incision was reopened, the ex-
pander was removed, and anterior capsulectomywas routinely
performed. The IMF was recreated if necessary. The measure-
ments of local tissue thickness were repeated and the implant
choice was reviewed. The definitive implant was selected and
inserted using standard aseptic methods.
Follow-up
Follow-up data drawn from prospective clinical records were
routinely recorded by the surgeon. In particular, we collected
the following information: date of the last follow-up in order to
calculate the duration in months, occurrence of complications,
cosmetic outcome including shape and symmetry, patients’
satisfaction level, presence of capsular contracture graded
according to Baker’s classification, and use of lipofilling. In
the group of complications requiring surgical intervention, we
recorded the need for revision surgery involving a change of
implant model. When estimating the rate of implant substitu-
tion due to an incorrect implant choice, we excluded those cases
of revision surgery done 5 years after a satisfactory outcome or
done for other medical reasons (e.g., change in body weight or
shape of the contralateral breast, or a new breast cancer).
Statistical analyses
To identify clinical factors that may lead to a perioperative
change in the selection of a breast implant, we used a multi-
variable logistic regression model. The model was adjusted
for BMI (as a continuous variable), preoperative planning
(complete vs partial markings), and type of contralateral breast
procedure (mastopexy, reduction mammaplasty, or augmenta-
tion vs no procedure). The results were reported as odds ratios
and 95% confidence intervals.
A multivariable logistic regression model was also fitted to
assess the impact of breast shape (width, height, and projec-
tion) on the likelihood of a change of implant choice. For the
calculation of odds ratios, the median preoperative measure-
ments were used as reference points. To take into account
possible non-linear effects, restricted cubic splines with three
knots were used [13]. All statistical analyses were done using
R3.02 for Windows, with the rms package added.
Results
A total of 496 women who underwent unilateral breast recon-
struction during the study period (Table 1) were included in
Fig. 1 Preoperative photographs
showing two complete drawings
of the following parameters:
width, height, and projection
(cm); midsternal line; and
inframammary fold level
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this retrospective analysis. About one quarter of the women
had unilateral breast reconstruction alone, while the remaining
patients had a contralateral procedure for symmetry, with aug-
mentation being more frequent than either mastopexy or re-
duction mammaplasty. A total of 308 implant choices (62.1%)
were changed perioperatively.
Among the implants selected preoperatively and those ac-
tually implanted (Table 2), the majority were from the
Natrelle 410 series, which has many more models than the
510 series. The implants with medium or full-height and
extra-full projection (MX and FX) were more frequently cho-
sen in both the preoperative and perioperative settings. In our
experience, these models are better able to restore the breast
profile that is usually flat after mastectomy and tissue atro-
phy, especially for medium-sized and large breasts. In partic-
ular, the most used 410 models were MX550 and LX625 in
large breasts; MX445 and MX410 in medium-sized breasts;
and MX325, FF290, and MF255 in small breasts. In four
cases, a round implant (110 or 120) was chosen in the peri-
operative setting, for better matching with the contralateral
breast and rebuilding of a lower pole overhanging the IMF
according to the reconstructive technique used in our institute
[14].
Factors associated with a change in implant choice
Multivariable logistic regression was used to identify clinical
factors associated with a perioperative change of the implant
model selected preoperatively (Table 3). The only variable
associated with a change in implant selection was the kind
of surgery. In particular, reconstruction with contralateral re-
duction showed an odds ratio of 1.92, i.e., the likelihood that
surgeons changed their plan was nearly twice as high as in
reconstruction alone. Similar results were obtained for patients
undergoing reconstruction and mastopexy (OR = 2.26). Other
factors were not significantly associated with a change of im-
plant selection.
A second analysis took into consideration the variations in
dimensions and weight of the implants between those chosen
preoperatively and those actually implanted (Table 4). The
median values of height and projection did not change, where-
as only small changes in median width and weight were re-
corded. More than one variable changed in 308 cases (62.1%);
width was less frequently changed (53.4%) while height
changed the most (67.7%). Width changed more than 0.5 cm
(the typical difference in size between consecutive models of
implants) in 70 cases (14.1%), while height changed more
than 0.5 cm in 215 cases (43.3%).
Histograms were plotted to illustrate the range of changes
in dimensions and weight (Fig. 2). Regarding the differences
Table 1 Clinical and surgical data regarding 496 women who had
unilateral mastectomy and two-stage breast reconstruction
Variable Value
Body mass index, mean (SD) 23.6 (3.7)
Preoperative markings, n (%)
Complete 259 (52.2)
Partial 237 (47.8)
Contralateral breast procedure, n (%)
None 127 (25.6)
Mastopexy 100 (20.2)
Reduction mammaplasty 110 (22.2)
Augmentation 159 (32.0)
Change in implant selection, n (%) 308 (62.1)
Table 2 Breast implants selected during preoperative planning and
actually implanted during breast reconstruction in 496 women
Implant
model
Preoperatively chosen model Implanted model
Cases, n Weight range, g Cases, n Weight range, g
410 series
LL 3 135–240 6 135–240
LM 10 190–320 13 190–320
LF 41 240–540 44 205–595
LX 37 290–625 43 255–685
ML 0 – 0 –
MM 11 245–400 21 240–450
MF 65 225–580 65 225–640
MX 197 225–685 166 225–685
FL 1 250 2 250
FM 4 270–670 1 310
FF 12 255–535 18 220–740
FX 101 280–690 88 315–775
510 series
LX 3 425 2 330–365
MX 11 335–550 19 335–490
FX 0 – 4 310–495
110 0 – 3 150–510
120 0 – 1 550
Table 3 Results of multivariable logistic regression to test the influence
of clinical parameters on the likelihood of a perioperative change in breast
implant selection
Factor Odds ratio (95% CI) P value
BMI (4 kg/m2 increment) 1.04 (0.82–1.32) 0.74
Preoperative markings
(complete vs partial)
0.87 (0.60–1.26) 0.47
Contralateral surgery 0.01
Mastopexy 2.26 (1.29–3.96)
Reduction mammaplasty 1.92 (1.12–3.29)
Augmentation 1.23 (0.75–2.00)
206 Eur J Plast Surg (2017) 40:203–212
in dimensions, the interquartile range (IQR), i.e., the range of
values that includes the central 50% of cases, was 0.5 cm
(−0.5 to 0 cm), 0.8 cm (−0.5 to 0.3 cm), and 0.2 cm (−0.1 to
0.1 cm) for width, height, and projection, respectively, while it
was 50 g (−35 to 15 g) for weight. For width, the IQR
corresponded to a change (0.5 cm) from one to the next size
in the catalog series, while for weight, the IQR (50 g) included
two or three models for every category of implant. The graphs
show that the highest bar is in the B−0.5 to 0 cm^ bin, where
the cases with no implant change were placed. For the linear
dimensions (Fig. 2a–c), changes of 1 cm or more were rare.
For weight (Fig. 2d), the graph illustrates that a few cases
required changes beyond 100 g in either direction.
Multivariable logistic regression was used to determine
the impact of breast dimensions on the likelihood of a peri-
operative change in implant selection. For this analysis, the
median value of each preoperative measurement as report-
ed in Table 4 was used as the reference value. The trends in
odds ratios for each dimension are illustrated in Fig. 3 and
summarized with a few examples in Table 5. For preoper-
ative width, the odds ratio for a change in implant was near
one for preoperative measurements <13 cm, but for larger
widths, it increased precipitously (Fig. 3a). These data sug-
gest that there is a high likelihood of changing the chosen
implant when the preoperatively measured width is large.
Regarding preoperative height measurements, the odds ra-
tio describing the likelihood of change was near one (sug-
gesting no perioperative change) for intermediate values,
while it was substantially above one for larger and above
two for smaller preoperative measurements (Fig. 3b).
Finally, in preoperative projection measurements, the odds
ratio curve deviated from one towards lower values with
projection values above 6.5 cm; these results suggest that a
change in implant choice is less likely when the projection
value is large.
Follow-up
Follow-up data were available for 459 patients (92.5%). The
mean follow-up at the time of this study was 16.6 months
(range, 4–124 months). Radiotherapy had been administered
in 37 cases. The oncological follow-up recorded four local
recurrences, eight contralateral cancers, and ten distant metas-
tases. Complications requiring a surgical intervention were
Fig. 2 Histograms of the variations in breast implant dimensions between the preoperative plan and the implant actually used. a Width. b Height. c
Projection. dWeight
Table 4 Dimensions and weight
of breast implants, according to
preoperative plan and as actually
implanted, for 496 women
Variable Preoperative choice,
median (range)
Implanted model,
median (range)
Cases that changed,
n (%)
Difference,
median (range)
Width, cm 13.0 (10.5–16.0) 13.5 (9.7–15.5) 265 (53.4) 0 (−4–2.5)
Height, cm 12.5 (8.6–16. 0) 12.5 (8.6–16.0) 336 (67.7) 0 (−2.9–2.9)
Projection, cm 6.0 (3.0–7.2) 6.0 (2.5–7.1) 297 (59.9) 0 (−3.0–2.7)
Weight, g 410 (135–690) 420 (135–775) 303 (61.1) 0 (−225–240)
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recorded in 53 patients (11.5%) including six cases in which
the implant was affected: four cases of infection or extrusion
(requiring implant removal after 2 months) and two cases of
skin necrosis treated by latissimus dorsi flaps and the use of a
smaller implant (Table 6). The rate of implant substitution
(considering only those cases attributable to a poor implant
choice and not to other factors) was 5.9%. In particular, 27
patients had their implant changed with a different model (24
operations in our hospital and three in other hospitals) in a
median period of 20 months (range, 2 to 50 months). Nine
of these patients had Baker grade III or IV capsular contrac-
tures. Only one case of implant substitution also had a
lipofilling procedure immediately, while four patients
Fig. 3 Relationship between preoperative breast dimensions and the odds ratio of a change of implant selection. The dashed line corresponds to no effect
of the predictor; shaded bands are pointwise 0.95 confidence limits for predicted odds ratio
Table 6 Follow-up data for 459 patients
Variable Cases, n (%)
Complications (requiring a surgical intervention) 53 (11.5)
Revision surgery for implant change 27 (5.9)
Breast shape
Good 308 (67.1)
Average 81 (17.6)
Poor 58 (12.6)
Data missing 12 (2.6)
Symmetry
Good 277 (60.3)
Average 145 (31.6)
Poor 25 (5.4)
Data missing 12 (2.6)
Patient satisfaction
Good 321 (69.9)
Average 102 (22.2)
Poor 24 (5.2)
Data missing 12 (2.6)
Capsular contracture
I normal 39 (8.5)
II 330 (71.9)
III 54 (11.7)
IV severe 4 (0.8)
Data missing 32 (6.9)
Remodeling by lipofilling 4 (0.8)
Table 5 Results of multivariable logistic regression in shape
measurements
Dimension Odds ratio (95% CI) P value
Width 0.0025
11.5 vs 13.0 0.99 (0.44–2.21)
14.0 vs 13.0 2.06 (1.25–3.39)
15.5 vs 13.0 9.66 (1.94–48.2)
Height 0.0420
10.5 vs 12.5 2.97 (1.47–6.00)
13.0 vs 12.5 1.27 (0.94–1.72)
14.5 vs 12.5 1.99 (0.91–4.31)
Projection 0.0050
4.2 vs 6.0 0.68 (0.28–1.63)
5.6 vs 6.0 0.44 (0.18–1.07)
7.1 vs 6.0 0.18 (0.05–0.61)
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underwent delayed lipofilling. The surgeons’ evaluation of
esthetic outcome was predominantly good for breast shape
(67.1%) and symmetry (60.3%), and 69.9% of patients also
reported a good level of satisfaction.
Discussion
To our knowledge, this is the first study to provide statistical
data on the preoperative selection of implants in two-stage
breast reconstruction. Our study shows that about 62% of
implant selections made in the preoperative period were
changed during surgery. Changes in implant dimensions were
generally less than 0.5 cm, requiring the surgeon to select the
next implant in the series. Width changes were less frequent
than height changes and occurred primarily with small im-
plants. Height changes were the most frequent changes and
were the least predictable for the greatest and smallest height
measurements. Projection changes accounted for a few milli-
meters only, in particular with projection values exceeding
6 cm. The likelihood of a change in implant selection was
higher when the preoperative breast width was >13 cm or
when contralateral surgery was planned, in particular
mastopexy (Fig. 4). The considerable influence of mastopexy
may be explained by the difficulty in predicting the projection
of the lifted breast, with particular attention being paid to
upper pole fullness.
This study reveals the importance of accurate measure-
ments of width and height of the breast, with weight having
lesser importance. This may entail a shift from round implants,
where volume was the optimal measure, to anatomical im-
plants, where shape and size can vary greatly despite similar
volume [15]. Width is the focal point of every implant choice
for reconstruction [9, 10].
The higher rate of change in implant height may reflect the
availability of devices offered by the manufacturer (low, me-
dium, full) for an individual base width; however, more tech-
nical reasons should also be considered, such as (1)
overexpansion of the upper pole by a temporary expander,
which can hide the actual soft tissue thickness and make an
accurate pinch test result more difficult to obtain; (2) rib cage
deformity after expansion, which may be appreciated once the
expander is removed (Fig. 5); (3) IMF level, which must be
planned preoperatively but is delineated perioperatively [14,
16]; and (4) grade of ptosis achievable in some cases using the
technique of inframammary remodeling (Fig. 6) [17]. This
procedure may result in changes in projection and shape to
fit the lowermost part of the implant in the hanging envelope
of the pocket (less projected anatomical implant and some-
times round implants).
The choice of projection showed the least variation, but this
may be partially due to the lower range of options compared
with those offered by width and height. Another reason may
be the preference for extra-projected models, reducing the
range available. It may be that the real variations can be ex-
plained either by the effect produced by contralateral surgery
or by thoracic flattening due to posterior expansion, which is
only assessable during the operation.
The appropriateness of the implant choice at the time of
surgery was confirmed by patient satisfaction and minimal
requests for surgical replacement of implants. Nevertheless,
more effort should be made to improve the predictability of
the preoperative plan. We could improve the preoperative plan
by measuring medial and lateral thickness more accurately in
the non-affected breast (especially when planning a
mastopexy) and not only at the mastectomy site. According
to the statistical outcomes, we should decrease the preselected
implant width by about 0.5 cm when it exceeds 13 cm and
mastopexy is planned. Otherwise, when planning a
mastopexy or breast reduction, we should always measure
the parenchyma thickness of the non-affected breast by the
pinch test medially and laterally, with the breast displaced
laterally and medially, respectively, so as to simulate medial
and lateral pillar advancement during surgery.
The search for a simple predictive formula for implant se-
lection is challenging, especially whenmultiple variables need
Fig. 4 Unilateral expander substitution and contralateral augmentation
without mastopexy. The preoperative photograph (left) and postoperative
photograph at 12 months (right) show the planned choices that were
selected during surgery (expander 133MX 500 cm3 changed with
410MX 550 g and ML 170 g in the contralateral breast)
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to be accounted for. These variables may be identified in the
preoperative planning stage and include certain characteristics
of the breast (skin envelope, scar tissue, muscle coverage, IMF
position, nipple position), as well as size and ptosis of the
opposite breast. Sigurdson and Kirkland used multiple linear
regression analysis of anthropomorphic measurements to de-
velop a formula to predict breast volume in case of breast
hypertrophy [18]. Descamps et al. used multiple regression
analysis to predict resection weight for reduction
mammoplasty [19].
The majority of decision-making methods for preoperative
planning do not come from the results of multivariable logistic
regressionmodels or, more generally, clinical studies. A recent
systematic review of implant size selection systems for breast
augmentation reports that only 12% of articles included out-
comes that could be compared to accepted literature values or
industry standards [20]. The present study has critically ad-
dressed this problem for breast reconstruction and searched
for mathematical intervals of confidence.
Chae et al. published a literature review concerning volu-
metric analysis for esthetic planning in breast reconstruction
spanning from 1950 to 2015 [21]. They argued that thermo-
plastic casting, direct anthropomorphic measurement, 2D im-
aging, and computed tomography/magnetic resonance imag-
ing scans have mostly been unreliable, difficult to execute,
and characterized by limited practicability. The only exception
is 3D surface imaging, even if limited by high costs and the
lack of a high level of evidence.
Breast implant surgery has been based on anthropometric
parameters and implant width, height, and projection, but we
are aware that no fully reliable methods are available in case of
asymmetrical breast surgery. The present study has tried to
quantify the risk of pitfalls. It shows that preoperative plan-
ning in breast reconstruction is still difficult and that implant
selection can be reevaluated intraoperatively when major re-
finements of the pocket or contralateral surgery are being
planned.
Volume/weight measurement is an important aspect. We
have analyzed the volume/weight differences in our study,
but we believe that volume information cannot be a selec-
tive parameter for choosing an anatomical implant, espe-
cially in breast reconstruction. Volume information is
Fig. 6 Unilateral expander substitution and contralateral augmentation
with round-block mastopexy. The preoperative photograph (left) shows
the selected implants; the postoperative view was taken at 12 months
(right). Planning foresaw the use of 410MX 325 g on the right and
410MM 185 g on the left. The reconstructive implant was altered to
410FM 350 g during surgical refinement. Based on the vertical
enlargement of the pocket produced by the soft tissue responsiveness
and the rebuilding of the inframammary fold, the implant parameters
were changed (more height and less projection)
Fig. 5 Unilateral expander substitution and contralateral augmentation.
The preoperative photograph (left) shows the implant selection, which
was altered during surgery. On the left side, the 133MV 300 cm3
expander was exchanged with 410FX 410 g, and on the right side, a
fixed-volume 410FL 190 g was placed. The postoperative photograph
demonstrates good symmetry at 24 months (right). The variations in
dimensions are as follows: left: width +0.5 cm, height +0.5 cm, and
projection +0.3 cm; right: width +1.0 cm, height +2.4 cm, projection
+0.2 cm
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useful for the patient’s comprehension of our planning; it is
also still useful for avoiding major sizing errors in case of
breast asymmetry.
The study confirms that width is of great importance in the
anthropometric methods of implant planning because it is the
factor with the least likelihood of change, while weight has
lesser importance. The height of the selected implant is at the
highest risk of being changed during surgery.
Although it has not been possible to statistically validate
a safe algorithm for implant selection in the preoperative
setting based on three dimensions, the results show that
preoperative measurements (in particular width) are signifi-
cantly more reliable in smaller implants (<335 g). Moreover,
preoperative selection of implant width can become reliable
with a tolerable margin of ±0.5 cm. Width should serve as a
starting point for implant selection and may vary, requiring
the availability of implant sizes above and below the select-
ed implant.
Surgeons should be aware of the lesser predictability of
implant selection in the case of contralateral surgery, in par-
ticular mastopexy, and when large implants are used. We rec-
ommend that clinics involved in breast reconstruction be
equipped with a large stock of implants in various shapes
and sizes.
In conclusion, the multivariable logistic regression model
demonstrates that preselection of implants with anthropomet-
ric evaluation alone in the case of contralateral mastopexy,
breast reduction, or augmention is rather difficult, with poten-
tial risks and a possible need for further intraoperative selec-
tion. Intraoperative recalculation of breast dimensions by ruler
and ultimately the use of sizers is required. This dual planning
selection system may have an advantage in terms of patient
reoperation rates.
In the future, novel advanced methods of breast volu-
metric analysis, such as web-based 3D surface imaging
programs, 4D imaging, and 3D printing, can help surgeons
perform reliable preoperative planning, thanks to their po-
tential advantages: efficiency, easy and fast application,
and low cost.
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